Vigilare Wealth Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Vigilare Wealth Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-30,300	Closed	-$273K	–	198
2021 Q3	$273K	Buy	30,300 +16,000	+112%	+$158K	0.17%	152
2021 Q2	$171K	Sell	14,300 -2,400	-14%	-$27.2K	0.1%	200
2021 Q1	$209K	Buy	16,700 +6,400	+62%	+$86.2K	0.15%	174
2020 Q4	$161K	Sell	10,300 -11,340	-52%	-$133K	0.15%	142
2020 Q3	$204K	Sell	21,640 -6,010	-22%	-$65K	0.21%	119
2020 Q2	$248K	Sell	27,650 -3,250	-11%	-$30.2K	0.25%	86
2020 Q1	$197K	Buy	30,900 +7,800	+34%	+$57.9K	0.24%	102
2019 Q4	$169K	Buy	+23,100	New	+$212K	0.11%	140

Other funds holding SGMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vigilare Wealth Management's SGMO Position: Q4 2021 in Review

Vigilare Wealth Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2021, closing a stake of 30,300 shares — an estimated $273K sold.

Vigilare Wealth Management first reported a position in SGMO in Q4 2019 and held it in 8 quarters. The position peaked at $273K in Q3 2021. 193 funds tracked by Wall St. Rank hold SGMO as of Q4 2021.

Vigilare Wealth Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2021 after selling out during the quarter.
Vigilare Wealth Management sold 30,300 SANGAMO THERAPEUTICS INC shares in Q4 2021, an estimated $273K.
Vigilare Wealth Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2019 and held it in 8 quarters.
Vigilare Wealth Management's SANGAMO THERAPEUTICS INC position peaked at $273K in Q3 2021.
193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2021.

Based on Vigilare Wealth Management's 13F filing for Q4 2021, filed 7 Jan 2022.